[Long-term follow-up of 52 endoluminal irradiated patients with central lung tumors].
The results of a prospective follow-up study comprising 52 patients with central tumours of the lung submitted to endoluminal irradiation are reported. Additional external irradiation was possible in 30 patients (group A), but not in 22 patients (group B). Satisfactory immediate results were observed, together with a one-year survival rate of 39.3% (group A) and 12.5% (group B).
Huber
R M
RM
Medizinische Klinik Innenstadt, Universität München.
Rohloff
R
R
Duft
S
S
Pforte
A
A
Häussinger
K
K
Mayr
B
B
Müller-Wening
D
D
D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy / Q000295:instrumentation*; D020680:Bronchoscopes; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007496:Iridium Radioisotopes / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy*; D011879:Radiotherapy Dosage
D007496:Iridium Radioisotopes
Langzeitverlauf von 52 endoluminal bestrahlten Patienten mit zentralen Lungentumoren.